ORIC Pharmaceuticals Ownership 2024 | Who Owns ORIC Pharmaceuticals Now?
Institutional Ownership
100.34%
Insider Ownership
9.13%
Retail Ownership
-9.47%
Institutional Holders
111.00
ORIC Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NEXTECH INVEST LTD. | 7.85% | 6.29% | 5,285,714 | - | - | 37,369,998 | Jun 30, 2024 |
| FMR LLC | 7.31% | 0.00% | 4,920,360 | -104,240 | -2.07% | 34,786,944 | Jun 30, 2024 |
| BLACKROCK INC. | 7.17% | 0.00% | 4,830,880 | 1,652,695 | 52.00% | 34,154,321 | Jun 30, 2024 |
| VR ADVISER, LLC | 6.53% | 1.98% | 4,394,527 | - | - | 31,069,306 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 6.15% | 1.37% | 4,142,855 | - | - | 29,289,985 | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | 5.94% | 0.11% | 4,000,000 | - | - | 28,280,000 | Jun 30, 2024 |
| ALKEON CAPITAL MANAGEMENT LLC | 5.65% | 0.04% | 3,804,096 | 100,000 | 2.70% | 26,894,959 | Jun 30, 2024 |
| COLUMN GROUP LLC | 5.26% | 35.12% | 3,540,777 | - | - | 25,033,293 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 5.08% | 0.74% | 3,418,068 | - | - | 24,165,741 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.75% | 0.00% | 3,199,726 | 317,671 | 11.02% | 22,622,061 | Jun 30, 2024 |
| STATE STREET CORP | 3.35% | 0.00% | 2,256,228 | 540,147 | 31.48% | 15,951,532,000 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 2.97% | 0.97% | 2,000,000 | - | - | 14,140,000 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 2.57% | 0.65% | 1,732,571 | - | - | 12,249,277 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 2.25% | 1.74% | 1,515,960 | 418,389 | 38.12% | 10,717,837 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 2.23% | 0.80% | 1,500,000 | - | - | 10,605,000 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 1.89% | 0.11% | 1,273,522 | -237,339 | -15.71% | 9,003,801 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 1.89% | 0.83% | 1,269,676 | 419,995 | 49.43% | 8,976,609 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.82% | 0.00% | 1,222,692 | 311,059 | 34.12% | 8,646,034 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.77% | 0.00% | 1,189,227 | -377,509 | -24.10% | 8,409,000 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.60% | 1.79% | 1,075,812 | -37,195 | -3.34% | 7,605,991 | Jun 30, 2024 |
ORIC Pharmaceuticals's largest institutional shareholder is NEXTECH INVEST LTD., holding 7.85% of the company's total share outstanding, currently valued at $37.37M. The top 10 institutional shareholders own together 61.67% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COLUMN GROUP LLC | 5.26% | 35.12% | 3,540,777 | - | - | 25,033,293 | Jun 30, 2024 |
| INVUS FINANCIAL ADVISORS, LLC | 1.50% | 7.98% | 1,007,575 | - | - | 7,123,555 | Jun 30, 2024 |
| NEXTECH INVEST LTD. | 7.85% | 6.29% | 5,285,714 | - | - | 37,369,998 | Jun 30, 2024 |
| VR ADVISER, LLC | 6.53% | 1.98% | 4,394,527 | - | - | 31,069,306 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.60% | 1.79% | 1,075,812 | -37,195 | -3.34% | 7,605,991 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 2.25% | 1.74% | 1,515,960 | 418,389 | 38.12% | 10,717,837 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 6.15% | 1.37% | 4,142,855 | - | - | 29,289,985 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 0.60% | 1.17% | 405,000 | - | - | 2,863,350 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 2.97% | 0.97% | 2,000,000 | - | - | 14,140,000 | Jun 30, 2024 |
| EUCLIDEAN CAPITAL LLC | 1.47% | 0.88% | 989,410 | - | - | 6,995,129 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 1.89% | 0.83% | 1,269,676 | 419,995 | 49.43% | 8,976,609 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 2.23% | 0.80% | 1,500,000 | - | - | 10,605,000 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 5.08% | 0.74% | 3,418,068 | - | - | 24,165,741 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 2.57% | 0.65% | 1,732,571 | - | - | 12,249,277 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 0.14% | 0.57% | 96,000 | -7,992 | -7.69% | 678,720 | Jun 30, 2024 |
| MONACO ASSET MANAGEMENT SAM | 0.45% | 0.34% | 301,650 | 171,650 | 132.04% | 2,132,666 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.05% | 0.14% | 36,643 | 36,643 | 100.00% | 259,066 | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | 5.94% | 0.11% | 4,000,000 | - | - | 28,280,000 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 1.89% | 0.11% | 1,273,522 | -237,339 | -15.71% | 9,003,801 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.24% | 0.10% | 163,000 | -258,000 | -61.28% | 1,152,410 | Jun 30, 2024 |
The largest ORIC Pharmaceuticals shareholder by % of total assets is COLUMN GROUP LLC. The company owns 3.54M shares of ORIC Pharmaceuticals (ORIC), representing 35.12% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 7.17% | 0.00% | 4,830,880 | 1,652,695 | 52.00% | 34,154,321 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.16% | 0.00% | 782,299 | 585,447 | 297.40% | 5,530,854 | Jun 30, 2024 |
| STATE STREET CORP | 3.35% | 0.00% | 2,256,228 | 540,147 | 31.48% | 15,951,532,000 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 1.89% | 0.83% | 1,269,676 | 419,995 | 49.43% | 8,976,609 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 2.25% | 1.74% | 1,515,960 | 418,389 | 38.12% | 10,717,837 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.75% | 0.00% | 3,199,726 | 317,671 | 11.02% | 22,622,061 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.82% | 0.00% | 1,222,692 | 311,059 | 34.12% | 8,646,034 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.69% | 0.00% | 466,662 | 305,860 | 190.21% | 3,298,548 | Jun 30, 2024 |
| MONACO ASSET MANAGEMENT SAM | 0.45% | 0.34% | 301,650 | 171,650 | 132.04% | 2,132,666 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.39% | 0.00% | 262,514 | 153,505 | 140.82% | 1,855,974 | Jun 30, 2024 |
| MORGAN STANLEY | 0.63% | 0.00% | 423,922 | 123,099 | 40.92% | 2,997,130 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.41% | 0.00% | 278,810 | 109,132 | 64.32% | 1,971,186 | Jun 30, 2024 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 0.15% | 0.04% | 102,434 | 102,434 | 100.00% | 724,208 | Jun 30, 2024 |
| ALKEON CAPITAL MANAGEMENT LLC | 5.65% | 0.04% | 3,804,096 | 100,000 | 2.70% | 26,894,959 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.41% | 0.00% | 276,489 | 75,367 | 37.47% | 1,954,777 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.28% | 0.00% | 186,484 | 71,394 | 62.03% | 1,318,442 | Jun 30, 2024 |
| SWISS NATIONAL BANK | 0.10% | 0.00% | 66,300 | 66,300 | 100.00% | 468,741,000 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.24% | 0.00% | 162,366 | 57,822 | 55.31% | 1,147,928 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.06% | 0.00% | 42,320 | 42,320 | 100.00% | 299,202 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.05% | 0.14% | 36,643 | 36,643 | 100.00% | 259,066 | Jun 30, 2024 |
As of Jun 30 2024, ORIC Pharmaceuticals's largest institutional buyer is BLACKROCK INC.. The company purchased 1.65M stocks of ORIC, valued at $34.15M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| INVESCO LTD. | 0.03% | - | 22,620 | -471,548 | -95.42% | 159,924 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.77% | 0.00% | 1,189,227 | -377,509 | -24.10% | 8,409,000 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.24% | 0.10% | 163,000 | -258,000 | -61.28% | 1,152,410 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.16% | 0.01% | 780,400 | -250,000 | -24.26% | 5,517,428 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 1.89% | 0.11% | 1,273,522 | -237,339 | -15.71% | 9,003,801 | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | - | - | - | -183,494 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -149,337 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | 7.31% | 0.00% | 4,920,360 | -104,240 | -2.07% | 34,786,944 | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | - | - | - | -96,468 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -80,000 | -100.00% | - | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | 0.21% | 0.00% | 139,400 | -69,200 | -33.17% | 985,558 | Jun 30, 2024 |
| FRED ALGER MANAGEMENT, LLC | 0.23% | 0.01% | 155,912 | -64,031 | -29.11% | 1,102,298 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.07% | 0.00% | 47,000 | -63,900 | -57.62% | 332,290 | Jun 30, 2024 |
| RATAN CAPITAL MANAGEMENT LP | - | - | - | -40,000 | -100.00% | - | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.60% | 1.79% | 1,075,812 | -37,195 | -3.34% | 7,605,991 | Jun 30, 2024 |
| OPTIONS SOLUTIONS, LLC | - | - | - | -33,451 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -31,900 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.02% | 0.00% | 16,229 | -28,485 | -63.70% | 115,000 | Jun 30, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | - | - | - | -23,100 | -100.00% | - | Jun 30, 2024 |
| NOMURA HOLDINGS INC | - | - | - | -20,512 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, ORIC Pharmaceuticals's biggest institutional seller is INVESCO LTD.. The company sold -0.47M shares of ORIC, valued at $159.92K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| HENNION & WALSH ASSET MANAGEMENT, INC. | 0.15% | 0.04% | 102,434 | 102,434 | 100.00% | 724,208 | Jun 30, 2024 |
| SWISS NATIONAL BANK | 0.10% | 0.00% | 66,300 | 66,300 | 100.00% | 468,741,000 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.06% | 0.00% | 42,320 | 42,320 | 100.00% | 299,202 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.05% | 0.14% | 36,643 | 36,643 | 100.00% | 259,066 | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | 0.05% | 0.00% | 36,223 | 36,223 | 100.00% | 256,097 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.05% | 0.00% | 34,228 | 34,228 | 100.00% | 241,992 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 33,124 | 33,124 | 100.00% | 234,187 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 23,899 | 23,899 | 100.00% | 168,266 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.03% | 0.03% | 22,815 | 22,815 | 100.00% | 161,302 | Jun 30, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | 0.03% | 0.03% | 21,738 | 21,738 | 100.00% | 153,688 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.03% | 0.01% | 21,638 | 21,638 | 100.00% | 152,981 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.03% | 0.00% | 19,723 | 19,723 | 100.00% | 139,442 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.02% | 0.00% | 10,760 | 10,760 | 100.00% | 76,074 | Jun 30, 2024 |
| GREAT WEST LIFE ASSURANCE CO /CAN/ | 0.01% | 0.00% | 8,324 | 8,324 | 100.00% | 59,000 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 1,105 | 1,105 | 100.00% | 7,812 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | - | - | 20 | 20 | 100.00% | 141 | Jun 30, 2024 |
ORIC Pharmaceuticals's largest new institutional shareholder by number of shares is HENNION & WALSH ASSET MANAGEMENT, INC., purchased 102.43K shares, valued at $724.21K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NICHOLAS INVESTMENT PARTNERS, LP | - | - | - | -183,494 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -149,337 | -100.00% | - | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | - | - | - | -96,468 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -80,000 | -100.00% | - | Jun 30, 2024 |
| RATAN CAPITAL MANAGEMENT LP | - | - | - | -40,000 | -100.00% | - | Jun 30, 2024 |
| OPTIONS SOLUTIONS, LLC | - | - | - | -33,451 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -31,900 | -100.00% | - | Jun 30, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | - | - | - | -23,100 | -100.00% | - | Jun 30, 2024 |
| NOMURA HOLDINGS INC | - | - | - | -20,512 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -19,236 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -16,372 | -100.00% | - | Jun 30, 2024 |
| PROSHARE ADVISORS LLC | - | - | - | -11,733 | -100.00% | - | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | - | - | - | -11,689 | -100.00% | - | Jun 30, 2024 |
| STRS OHIO | - | - | - | -7,400 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -5,700 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -2,149 | -100.00% | - | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -281 | -100.00% | - | Jun 30, 2024 |
| FEDERATED HERMES, INC. | - | - | - | -152 | -100.00% | - | Jun 30, 2024 |
| NBC SECURITIES, INC. | - | - | - | -118 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -8 | -100.00% | - | Jun 30, 2024 |
ORIC Pharmaceuticals's largest sold out institutional shareholder by shares sold is NICHOLAS INVESTMENT PARTNERS, LP, sold -0.18M shares, valued at -, as of undefined.
ORIC Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| CORNERCAP GROUP OF FUNDS /VA/ | 0.48% | 34,870 | 18,840 | 117.53% | Sep 30, 2022 |
| MERIDIAN FUND INC | 0.31% | 728,613 | -113,324 | -13.46% | Mar 28, 2024 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.18% | 531,690 | 8,707 | 1.66% | Mar 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.17% | 344,041 | - | - | Feb 29, 2024 |
| ACAP Strategic Fund | 0.12% | 1,821,398 | 59,535 | 3.38% | Mar 31, 2024 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.11% | 70,946 | - | - | Feb 29, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.08% | 39,270 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.07% | 185,615 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.07% | 581,716 | -405,000 | -41.05% | Jan 31, 2024 |
| ALLSPRING VARIABLE TRUST | 0.06% | 40,140 | - | - | Mar 31, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.06% | 22,193 | - | - | Mar 31, 2024 |
| CYPRESS CREEK PRIVATE STRATEGIES MASTER FUND L P | 0.05% | 93,497 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.05% | 24,507 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.04% | 1,111,284 | -37,408 | -3.26% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.03% | 80,000 | - | - | Mar 31, 2024 |
| PRUDENTIAL JENNISON SMALL CO FUND, INC. | 0.03% | 128,265 | - | - | Mar 28, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.03% | 234,001 | - | - | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.02% | 1,931,053 | 304,114 | 18.69% | Jan 31, 2024 |
| MATTHEWS INTERNATIONAL FUNDS | 0.01% | 191,568 | - | - | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 74,952 | -13,250 | -15.02% | Aug 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 68,909 | -3,753 | -5.17% | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 34,682 | - | - | Feb 29, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 6,049 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.01% | 22,500 | - | - | Mar 28, 2024 |
| Voya EQUITY TRUST | 0.01% | 12,957 | - | - | Feb 29, 2024 |
| FIDELITY CAPITAL TRUST | 0.01% | 88,792 | -324,208 | -78.50% | Jan 31, 2024 |
| ETFis Series Trust I | 0.01% | 8,939 | -3,975 | -30.78% | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,547,390 | -116,769 | -4.38% | Mar 31, 2024 |
| FINANCIAL INVESTORS TRUST | 0.01% | 409,500 | - | - | Jan 31, 2024 |
| Humankind Benefit Corp | 0.00% | 109 | - | - | Dec 31, 2023 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 196,800 | - | - | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 672 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 34,060 | -13,471 | -28.34% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 106,601 | 719 | 0.68% | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 53,200 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 39,840 | -24,012 | -37.61% | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 58,480 | -24,150 | -29.23% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 385,682 | 28,563 | 8.00% | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 117,400 | - | - | Feb 29, 2024 |
| Managed Portfolio Series | 0.00% | 34,870 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.00% | 12,700 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 385,587 | 63,452 | 19.70% | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 37,327 | 4,559 | 13.91% | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 3,223 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 284,764 | -174,137 | -37.95% | Jan 31, 2024 |
| AdvisorShares Trust | 0.00% | 2,513 | - | - | Mar 28, 2024 |
| BlackRock ETF Trust | 0.00% | 493 | - | - | Jan 31, 2024 |
| ProFunds | 0.00% | 5,946 | 5,617 | 1707.29% | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 54,859 | 15,129 | 38.08% | Feb 29, 2024 |
| Global X Funds | 0.00% | 20,681 | - | - | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 85,899 | - | - | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 13,029 | -3,428 | -20.83% | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 4,554 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,740 | -400 | -18.69% | Mar 31, 2024 |
| Trust for Advised Portfolios | 0.00% | 7,007 | - | - | Dec 31, 2023 |
| Columbia Funds Variable Series Trust II | 0.00% | 10,998 | - | - | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 82,429 | - | - | Feb 29, 2024 |
| UBS FUNDS | 0.00% | 1,596 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 684 | - | - | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 141,100 | - | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 13,200 | - | - | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 17,938 | 17,938 | - | Feb 29, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 724,972 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 24,086 | 420 | 1.77% | Mar 28, 2024 |
| Dimensional ETF Trust | 0.00% | 61,373 | 55,279 | 907.11% | Jan 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 72 | - | - | Apr 30, 2021 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 2,484 | 332 | 15.43% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 1,796,029 | -29,444 | -1.61% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 112,868 | 19,977 | 21.51% | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 2,791 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 171,593 | 19,032 | 12.48% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 357 | - | - | Dec 31, 2023 |
| ALLSPRING FUNDS TRUST | 0.00% | 29,969 | - | - | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 7,129 | -30 | -0.42% | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 3,414 | - | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 14,979 | -61 | -0.41% | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 5,876 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 177 | - | - | Dec 31, 2023 |
| PROSHARES TRUST | 0.00% | 10,750 | 5,707 | 113.17% | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 3,669 | 2,028 | 123.58% | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,100 | -400 | -26.67% | Mar 28, 2024 |
| TIAA-CREF FUNDS | 0.00% | 114,782 | - | - | Jan 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 12,728 | 10,012 | 368.63% | Feb 29, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 188 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 88,727 | 10,787 | 13.84% | Dec 31, 2023 |
| RBB FUND, INC. | 0.00% | 2,486 | - | - | Feb 29, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS 2 | 0.00% | 5,216 | - | - | Jan 31, 2024 |
| SPDR SERIES TRUST | 0.00% | 926,067 | 226,420 | 32.36% | Mar 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 77,240 | - | - | Mar 28, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 53,253 | 1,829 | 3.56% | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 23 | - | - | Dec 31, 2023 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,978 | 699 | 54.65% | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 19,543 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 37,381 | 11,439 | 44.09% | Mar 31, 2024 |
| Franklin Alternative Strategies Funds | 0.00% | 9,045 | - | - | Feb 29, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 7,279 | - | - | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 13,189 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 13,506 | -913 | -6.33% | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 4,422 | -18 | -0.41% | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 712 | - | - | Feb 29, 2024 |
ORIC Pharmaceuticals's largest mutual fund holder by % of total assets is "CORNERCAP GROUP OF FUNDS /VA/", owning 34.87K shares, compromising 0.48% of its total assets.
ORIC Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 111 | -2.63% |
| 31 Mar, 24 | 114 | 20.00% |
| 31 Dec, 23 | 95 | 4.40% |
| 30 Sep, 23 | 91 | 3.41% |
| 30 Jun, 23 | 88 | 18.92% |
| 31 Mar, 23 | 74 | 7.25% |
| 31 Dec, 22 | 69 | -10.39% |
| 30 Sep, 22 | 77 | -9.41% |
| 30 Jun, 22 | 85 | -14.14% |
| 31 Mar, 22 | 99 | 25.32% |
| 31 Dec, 21 | 79 | -2.47% |
| 30 Sep, 21 | 81 | 3.85% |
| 30 Jun, 21 | 78 | -8.24% |
| 31 Mar, 21 | 85 | 11.84% |
| 31 Dec, 20 | 76 | 40.74% |
| 30 Sep, 20 | 54 | -18.18% |
| 30 Jun, 20 | 66 | - |
As of 30 Jun 24, 111 institutions are holding ORIC Pharmaceuticals's shares, representing a decrease of -2.63% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 67,581,249 | 5.85% |
| 31 Mar, 24 | 63,846,117 | 26.08% |
| 31 Dec, 23 | 50,638,927 | 5.41% |
| 30 Sep, 23 | 48,041,195 | 5.50% |
| 30 Jun, 23 | 45,537,877 | 37.68% |
| 31 Mar, 23 | 33,075,099 | 0.91% |
| 31 Dec, 22 | 32,775,733 | 0.22% |
| 30 Sep, 22 | 32,703,022 | -0.42% |
| 30 Jun, 22 | 32,840,424 | -3.42% |
| 31 Mar, 22 | 34,003,845 | -2.38% |
| 31 Dec, 21 | 34,831,269 | -4.33% |
| 30 Sep, 21 | 36,409,445 | 0.73% |
| 30 Jun, 21 | 36,145,633 | 1.28% |
| 31 Mar, 21 | 35,688,522 | 9.45% |
| 31 Dec, 20 | 32,607,869 | 47.20% |
| 30 Sep, 20 | 22,151,990 | 2.96% |
| 30 Jun, 20 | 21,514,508 | - |
ORIC Pharmaceuticals (ORIC) has 67.58M shares outstanding as of 30 Jun 24, up 5.85% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 100.34% | 1.12% |
| 31 Mar, 24 | 94.80% | 1.22% |
| 31 Dec, 23 | 88.12% | 1.26% |
| 30 Sep, 23 | 83.69% | 0.84% |
| 30 Jun, 23 | 99.75% | 1.85% |
| 31 Mar, 23 | 73.35% | 1.10% |
| 31 Dec, 22 | 81.57% | 1.19% |
| 30 Sep, 22 | 82.63% | 1.19% |
| 30 Jun, 22 | 83.18% | 1.12% |
| 31 Mar, 22 | 86.23% | 1.02% |
| 31 Dec, 21 | 91.77% | 1.05% |
| 30 Sep, 21 | 93.34% | 0.96% |
| 30 Jun, 21 | 98.48% | 1.04% |
| 31 Mar, 21 | 97.30% | 0.44% |
| 31 Dec, 20 | 148.61% | 2.78% |
| 30 Sep, 20 | 73.07% | 0.74% |
| 30 Jun, 20 | 99.48% | - |
As of 30 Jun 24, ORIC Pharmaceuticals is held by 100.34% institutional shareholders, representing a 1.12% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 74 | 10.45% |
| 31 Mar, 24 | 67 | 17.54% |
| 31 Dec, 23 | 57 | 39.02% |
| 30 Sep, 23 | 41 | -28.07% |
| 30 Jun, 23 | 57 | 58.33% |
| 31 Mar, 23 | 36 | 38.46% |
| 31 Dec, 22 | 26 | -16.13% |
| 30 Sep, 22 | 31 | -31.11% |
| 30 Jun, 22 | 45 | -16.67% |
| 31 Mar, 22 | 54 | 35.00% |
| 31 Dec, 21 | 40 | -6.98% |
| 30 Sep, 21 | 43 | -4.44% |
| 30 Jun, 21 | 45 | -10.00% |
| 31 Mar, 21 | 50 | -25.37% |
| 31 Dec, 20 | 67 | 168.00% |
| 30 Sep, 20 | 25 | -62.12% |
| 30 Jun, 20 | 66 | - |
74 institutional shareholders have increased their position in ORIC stock as of 30 Jun 24 compared to 67 in the previous quarter (a 10.45% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 19 | -32.14% |
| 31 Mar, 24 | 28 | 40.00% |
| 31 Dec, 23 | 20 | -28.57% |
| 30 Sep, 23 | 28 | 47.37% |
| 30 Jun, 23 | 19 | 11.76% |
| 31 Mar, 23 | 17 | -22.73% |
| 31 Dec, 22 | 22 | -18.52% |
| 30 Sep, 22 | 27 | 28.57% |
| 30 Jun, 22 | 21 | -16.00% |
| 31 Mar, 22 | 25 | 13.64% |
| 31 Dec, 21 | 22 | 10.00% |
| 30 Sep, 21 | 20 | 17.65% |
| 30 Jun, 21 | 17 | 21.43% |
| 31 Mar, 21 | 14 | 100.00% |
| 31 Dec, 20 | 7 | -53.33% |
| 30 Sep, 20 | 15 | - |
| 30 Jun, 20 | - | - |
19 institutional shareholders have reduced their position in ORIC stock as of 30 Jun 24 compared to 28 in the previous quarter (a -32.14% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 111 | -2.63% | 67,581,249 | 5.85% | 100.34% | 1.12% | 74 | 10.45% | 19 | -32.14% |
| 31 Mar, 24 | 114 | 20.00% | 63,846,117 | 26.08% | 94.80% | 1.22% | 67 | 17.54% | 28 | 40.00% |
| 31 Dec, 23 | 95 | 4.40% | 50,638,927 | 5.41% | 88.12% | 1.26% | 57 | 39.02% | 20 | -28.57% |
| 30 Sep, 23 | 91 | 3.41% | 48,041,195 | 5.50% | 83.69% | 0.84% | 41 | -28.07% | 28 | 47.37% |
| 30 Jun, 23 | 88 | 18.92% | 45,537,877 | 37.68% | 99.75% | 1.85% | 57 | 58.33% | 19 | 11.76% |
| 31 Mar, 23 | 74 | 7.25% | 33,075,099 | 0.91% | 73.35% | 1.10% | 36 | 38.46% | 17 | -22.73% |
| 31 Dec, 22 | 69 | -10.39% | 32,775,733 | 0.22% | 81.57% | 1.19% | 26 | -16.13% | 22 | -18.52% |
| 30 Sep, 22 | 77 | -9.41% | 32,703,022 | -0.42% | 82.63% | 1.19% | 31 | -31.11% | 27 | 28.57% |
| 30 Jun, 22 | 85 | -14.14% | 32,840,424 | -3.42% | 83.18% | 1.12% | 45 | -16.67% | 21 | -16.00% |
| 31 Mar, 22 | 99 | 25.32% | 34,003,845 | -2.38% | 86.23% | 1.02% | 54 | 35.00% | 25 | 13.64% |
| 31 Dec, 21 | 79 | -2.47% | 34,831,269 | -4.33% | 91.77% | 1.05% | 40 | -6.98% | 22 | 10.00% |
| 30 Sep, 21 | 81 | 3.85% | 36,409,445 | 0.73% | 93.34% | 0.96% | 43 | -4.44% | 20 | 17.65% |
| 30 Jun, 21 | 78 | -8.24% | 36,145,633 | 1.28% | 98.48% | 1.04% | 45 | -10.00% | 17 | 21.43% |
| 31 Mar, 21 | 85 | 11.84% | 35,688,522 | 9.45% | 97.30% | 0.44% | 50 | -25.37% | 14 | 100.00% |
| 31 Dec, 20 | 76 | 40.74% | 32,607,869 | 47.20% | 148.61% | 2.78% | 67 | 168.00% | 7 | -53.33% |
| 30 Sep, 20 | 54 | -18.18% | 22,151,990 | 2.96% | 73.07% | 0.74% | 25 | -62.12% | 15 | - |
| 30 Jun, 20 | 66 | - | 21,514,508 | - | 99.48% | - | 66 | - | - | - |
ORIC Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of ORIC Pharmaceuticals's stock was made by Kunkel Lori Anne on Jun 04 2024, selling 20,500 shares at $3.75 per share (valued at $76.88K).
ORIC Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 6 | 1 | 600.00% |
| Q1 2024 | 6 | 3 | 200.00% |
| Q4 2023 | 2 | 10 | 20.00% |
| Q3 2023 | - | 3 | - |
| Q2 2023 | 5 | 1 | 500.00% |
| Q1 2023 | 6 | - | - |
| Q4 2022 | 3 | 10 | 30.00% |
| Q3 2022 | 10 | 10 | 100.00% |
| Q2 2022 | 11 | - | - |
| Q1 2022 | 10 | - | - |
| Q4 2021 | 6 | 3 | 200.00% |
| Q3 2021 | 1 | 11 | 9.09% |
| Q2 2021 | 5 | 36 | 13.89% |
| Q1 2021 | 3 | 28 | 10.71% |
| Q4 2020 | - | 1 | - |
| Q2 2020 | 32 | 38 | 84.21% |
6 total buy trades, and 1 total sell trades (buy/sell ratio of 6.00%) were made by ORIC Pharmaceuticals's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | 3 | - |
| Q4 2023 | - | 3 | - |
| Q3 2023 | - | 3 | - |
| Q2 2023 | - | 1 | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | 6 | - |
| Q3 2022 | - | - | - |
| Q2 2022 | 3 | - | - |
| Q1 2022 | 4 | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | 11 | - |
| Q2 2021 | - | 36 | - |
| Q1 2021 | - | 28 | - |
| Q4 2020 | - | 1 | - |
| Q2 2020 | 2 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of ORIC Pharmaceuticals's stocks.
ORIC Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| PMVP | PMV Pharmaceuticals, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| SEER | Seer, Inc. |
| DBTX | Decibel Therapeutics, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| ANTX | AN2 Therapeutics, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| PHVS | Pharvaris N.V. |
| HOWL | Werewolf Therapeutics, Inc. |
| IMRX | Immuneering Corporation |
| PEPG | PepGen Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| MOLN | Molecular Partners AG |
| CELC | Celcuity Inc. |
| ELVN | Enliven Therapeutics, Inc. |
ORIC Ownership FAQ
Who Owns ORIC Pharmaceuticals?
ORIC Pharmaceuticals is owned by institutional shareholders (100.34%), insiders (9.13%), and public (-9.47%). The largest institutional shareholder of ORIC Pharmaceuticals is NEXTECH INVEST LTD. (7.85% of total shares) and the top mutual fund owner is CORNERCAP GROUP OF FUNDS /VA/ (0.48% of total shares).
Who are the major institutional shareholders of ORIC Pharmaceuticals?
ORIC Pharmaceuticals's major institutional shareholders are NEXTECH INVEST LTD., FMR LLC, BLACKROCK INC., VR ADVISER, LLC, and FRAZIER LIFE SCIENCES MANAGEMENT, L.P.. The top five shareholders own together 35.00% of the company's share outstanding.
How many ORIC Pharmaceuticals shareholders are there?
As of Jun 2024, there are 111 institutional shareholders of ORIC Pharmaceuticals.
What percentage of ORIC Pharmaceuticals is owned by NEXTECH INVEST LTD?
NEXTECH INVEST LTD owns 5.29M shares of ORIC Pharmaceuticals, representing 7.85% of the company's total shares outstanding, valued at $37.37M (as of Jun 2024).
What percentage of ORIC Pharmaceuticals is owned by FMR LLC?
As of Jun 2024, FMR LLC holds 4.92M shares of ORIC Pharmaceuticals (ORIC), compromising 7.31% of the company, valued at $34.79M.
What percentage of ORIC Pharmaceuticals is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of ORIC Pharmaceuticals. The company owns 4.83M of the company's shares outstanding (worth $34.15M).